Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.45 |
| ▸ | CTSS | P25774 | 3/20 | 0.45 |
| ▸ | CTSK | P43235 | 3/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6796546 | 0.85 | REN (0.45) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL6916267 | 0.83 | CTSK (0.46) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL6830642 | 0.81 | CTSK (0.47) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL6796549 | 0.78 | PPARG (0.45) | CTSSCTSKCTSLCTSB | |
| SCHEMBL11599291 | 0.76 | ACE (0.50) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL10624936 | 0.76 | CTSS (0.44) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL10622245 | 0.76 | CTSS (0.44) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL11101942 | 0.74 | ABCB1 (0.44) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL7618822 | 0.74 | REN (0.67) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL4420859 | 0.74 | REN (0.67) | RENCTSSCTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | REN 343/4885CTSS 1861/4885CTSK 2457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.